Triple immunotherapy for rare skin cancer shows promise in small, early-stage trial
Three out of four patients treated with an experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma are in complete remission following the treatment, according to study ...
May 30, 2017
0
1